STOCK OPTION PLAN KEY TERMS
Athens, August 2, 2024
ANNOUNCEMENT
STOCK OPTION PLAN KEY TERMS
The Board of Directors of Attica Holdings S.A. (hereinafter referred to as the "Company") convened
on August 1, 2024, and elaborated on the specification of the terms of the Stock Option Plan for the
acquisition of Company shares (the 'Options' and the 'Plan' respectively), and the allocation of the
Options to beneficiaries acting upon the resolution of the Annual General Meeting held on July 12,
2024.
The key terms of the Plan are outlined as follows:
- The beneficiaries of the Plan are executive members of the Board of Directors (the ‘BoD’) and
executives of the Company and its affiliated entities, as defined in Article 32 of L. 4308/2014, including
individuals who provide services to the Company and its affiliated entities on an ongoing basis as
defined in Article 113 of Law 4548/2018 (the ‘Beneficiaries’).
- The maximum number of new shares to be issued amounts to 5,500,000 voting ordinary registered
shares of a nominal value of thirty cents (€0.30) each, representing 2.26% of current share capital,
and will stem from an increase in the Company’s share capital. During the aforementioned meeting,
the BoD granted to Beneficiaries 4,912,500 Options for the acquisition, upon their exercise, of an
equivalent number of new Company shares. In the event of any corporate events which, in the
discretion of the BoD, modify the features of the existing shares of the Company (such as stock splits
or reverse stock splits without modifying the share capital through either a reduction or an increase in
the nominal value of each share, conversions, mergers, etc.), the BoD will make corresponding
adjustments to the number of shares to be acquired by the Beneficiaries of the Options exercised.
- The exercise price of the new shares has been set at two euros and twenty-five cents (€2.25) per
share. In the event of corporate events that necessitate adjustments to the number of shares to be
acquired by the Beneficiaries upon exercise of their Options, or otherwise impact the exercise price at
the discretion of the BoD, the exercise price may be accordingly adjusted by the BoD to reflect these
changes.
- The Plan is designated for a period of up to five (5) years (with the vesting period beginning from the
BoD decision date and extending in phases up to three years thereon, followed by an exercise period
of up to two years from the conclusion of the final vesting phase for each Beneficiary's Options).